Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer's disease. (2021)

First Author: Jones RE
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-021-94324-z

PubMed Identifier: 34294785

Publication URI: http://europepmc.org/abstract/MED/34294785

Type: Journal Article/Review

Volume: 11

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322